Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Carcinogenesis

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/carcin/bgp176PMID 19608619PMCID PMC3656619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulforaphane but not ascorbigen, indole‐3‐carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase‐2 and antioxidant enzymes in human keratinocytes in culture

  2010cited by this paper
• Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents.

  2009cited by this paper
• NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.

  2009cited by this paper
• Genomics of Smoking Exposure and Cessation: Lessons for Cancer Prevention and Treatment

  2008cited by this paper
• Loss of Keap 1 Function Activates Nrf 2 and Provides Advantages for Lung Cancer Cell Growth

  2008cited by this paper
• Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

  2008cited by this paper
• Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.

  2008cited by this paper
• Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity

  2008cited by this paper
• Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells

  2008cited by this paper
• Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.

  2008cited by this paper
• BACH1 Is a Specific Repressor of HMOX1 That Is Inactivated by Arsenite*

  2008cited by this paper
• The significance of Nrf2 pathway in (photo)‐oxidative stress response in melanocytes and keratinocytes of the human epidermis

  2007cited by this paper
• Consuming broccoli does not induce genes associated with xenobiotic metabolism and cell cycle control in human gastric mucosa.

  2007cited by this paper
• Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1

  2007cited by this paper
• Electrophilic chemicals but not UV irradiation or reactive oxygen species activate Nrf2 in keratinocytes in vitro and in vivo.

  2007cited by this paper
• Bach1 Repression of Ferritin and Thioredoxin Reductase1 Is Heme-sensitive in Cells and in Vitro and Coordinates Expression with Heme Oxygenase1, β-Globin, and NADP(H) Quinone (Oxido) Reductase1*

  2007cited by this paper
• Induction of the Phase 2 Response in Mouse and Human Skin by Sulforaphane-containing Broccoli Sprout Extracts

  2007cited by this paper
• Aldo-keto reductases and bioactivation/detoxication.

  2007cited by this paper
• Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

  2007cited by this paper
• Aldo–keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention

  2007cited by this paper
• BRG1 Interacts with Nrf2 To Selectively Mediate HO-1 Induction in Response to Oxidative Stress

  2006cited by this paper
• Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids.

  2006cited by this paper
• Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy

  2006cited by this paper
• Rosetta error model for gene expression analysis

  2006cited by this paper
• Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer

  2006cited by this paper
• Dimerization of Substrate Adaptors Can Facilitate Cullin-mediated Ubiquitylation of Proteins by a “Tethering” Mechanism

  2006cited by this paper
• Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2

  2006cited by this paper
• Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents.

  2006cited by this paper
• Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity.

  2006cited by this paper
• Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum.

  2006cited by this paper
• Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice.

  2006cited by this paper
• (www.interscience.wiley.com) DOI: 10.1002/path.2039

  2006cited by this paper
• Induction of AKR 1 C 2 by Phase II Inducers : Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF 2

  2006cited by this paper
• Heme Oxygenase-1 Gene Enhancer Manifests Silencing Activity in a Chromatin Environment Prior to Oxidative Stress

  2006cited by this paper
• Expression profile of malignant and nonmalignant lesions of esophagus and stomach: differential activity of functional modules related to inflammation and lipid metabolism.

  2005cited by this paper
• Nutrient-Gene Interactions Transcriptome Analysis of Human Colon Caco-2 Cells Exposed to Sulforaphane 1 – 3

  2005cited by this paper
• Bach1 Competes with Nrf2 Leading to Negative Regulation of the Antioxidant Response Element (ARE)-mediated NAD(P)H:Quinone Oxidoreductase 1 Gene Expression and Induction in Response to Antioxidants*

  2005cited by this paper
• Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas

  2005cited by this paper
• Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.

  2005cited by this paper
• Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype.

  2005cited by this paper
• Detection and identification of tumor‐associated protein variants in human hepatocellular carcinomas

  2004cited by this paper
• Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex

  2004cited by this paper
• Chemical structures of inducers of nicotinamide quinone oxidoreductase 1 (NQO1).

  2004cited by this paper
• Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2

  2004cited by this paper
• Heme regulates gene expression by triggering Crm1‐dependent nuclear export of Bach1

  2004cited by this paper
• Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers

  2004cited by this paper
• Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.

  2004cited by this paper
• Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression*

  2003cited by this paper
• Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence.

  2003cited by this paper
• Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway IDENTIFICATION OF NOVEL GENE CLUSTERS FOR CELL SURVIVAL*

  2003cited by this paper
• Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway

  2003cited by this paper
• Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress

  2003cited by this paper
• Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation

  2003cited by this paper
• Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray.

  2002cited by this paper
• Microarray Analysis Reveals an Antioxidant Responsive Element-driven Gene Set Involved in Conferring Protection from an Oxidative Stress-induced Apoptosis in IMR-32 Cells*

  2002cited by this paper
• Activation of Polycyclic Aromatic Hydrocarbontrans-Dihydrodiol Proximate Carcinogens by Human Aldo-keto Reductase (AKR1C) Enzymes and Their Functional Overexpression in Human Lung Carcinoma (A549) Cells*

  2002cited by this paper
• Hemoprotein Bach1 regulates enhancer availability of heme oxygenase‐1 gene

  2002cited by this paper
• Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1

  2001cited by this paper
• Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines.

  2001cited by this paper
• Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: The indirect antioxidant effects of sulforaphane

  2001cited by this paper
• Potent induction of phase 2 enzymes in human prostate cells by sulforaphane.

  2001cited by this paper
• The reactive oxygen species--and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene.

  2001cited by this paper
• Regulation of γ-glutamylcysteine synthetase subunit gene expression: Insights into transcriptional control of antioxidant defenses

  2000cited by this paper
• The Reactive Oxygen Species- and Michael Acceptor-inducible Human Aldo-Keto Reductase AKR1C1 Reduces the α,β-Unsaturated Aldehyde 4-Hydroxy-2-nonenal to 1,4-Dihydroxy-2-nonene*

  2000cited by this paper
• Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.

  2000cited by this paper
• Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.

  1999cited by this paper
• Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.

  1999cited by this paper
• An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site.

  1998cited by this paper
• An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site.

  1998cited by this paper
• Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long‐term culture of the human keratinocyte line HaCaT

  1997cited by this paper
• Constitutive and β-Naphthoflavone-induced Expression of the Human γ-Glutamylcysteine Synthetase Heavy Subunit Gene Is Regulated by a Distal Antioxidant Response Element/TRE Sequence*

  1997cited by this paper
• The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors.

  1996cited by this paper
• Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics.

  1994cited by this paper
• Glutathione-associated enzymes in anticancer drug resistance.

  1994cited by this paper
• p53 mutations in human immortalized epithelial cell lines.

  1993cited by this paper
• Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element.

  1992cited by this paper
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

  1969cited by this paper

• AKR1C inhibitors medroxyprogesterone acetate and mefenamic acid exhibit antitumor activity alone and combined with carboplatin in platinum-resistant high-grade serous ovarian cancer models.

  2026cites this paper
• An Activity-Based Sensing Approach to Monitor Nanomaterial-Promoted Changes in Labile Metal Pools in Living Systems

  2026cites this paper
• NRF2: Master regulator of cellular homeostasis and therapeutic vulnerability in cancer

  2026cites this paper
• Allosecurinine Derivative with Two Michael Acceptors Activates Keap1-Nrf2 Pathway.

  2026cites this paper
• Dissecting the Interplay Between NRF2 and BACH1 at CsMBEs

  2025cites this paper
• Modulation of Nrf2 and Mitochondrial Function: Pharmacological Implications

  2025cites this paper
• A microarray assessment of the modulation of human oxidative stress gene expression by rooibos and honeybush tea extracts in UVB-irradiated keratinocytes

  2025cites this paper
• The clinical-grade CBP/ p300 inhibitor CCS1477 represses the global NRF2-dependent cytoprotective transcription program and re-sensitizes cancer cells to chemotherapeutic drugs.

  2025cites this paper
• Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis.

  2025cites this paper
• Glutathione S-transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide-induced ferroptosis in pancreatic ductal adenocarcinoma.

  2025cites this paper
• The human PTGR1 gene expression is controlled by TE-derived Z-DNA forming sequence cooperating with miR-6867-5p

  2024cites this paper
• Nrf2 as a regulator of energy metabolism and mitochondrial function

  2024cites this paper
• Prolonged Cadmium Exposure and Osteoclastogenesis: A Mechanistic Mouse and in Vitro Study

  2024cites this paper
• Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway.

  2024cites this paper
• Enhancing NADPH to restore redox homeostasis and lysosomal function in G6PD-deficient microglia

  2024cites this paper
• Biomarkers of NRF2 signalling: Current status and future challenges

  2024cites this paper
• Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids

  2024cites this paper
• Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling.

  2023cites this paper
• IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer

  2023cites this paper
• N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant

  2023cites this paper
• Insulin-Induced AKR1C3 Induces Fatty Acid Synthase in a Model of Human PCOS Adipocytes.

  2023cites this paper
• Nrf2 for a key member of redox regulation: A novel insight against myocardial ischemia and reperfusion injuries.

  2023cites this paper
• Nrf2 regulates glucose uptake and metabolism in neurons and astrocytes

  2023cites this paper
• Deletion of BACH1 alleviates ferroptosis and protects against LPS-triggered acute lung injury by activating Nrf2/HO-1 signaling pathway.

  2023cites this paper
• Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer.

  2023cites this paper
• The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory Infections

  2023cites this paper
• Acute Oxidative Stress Can Paradoxically Suppress Human NRF2 Protein Synthesis by Inhibiting Global Protein Translation

  2023cites this paper
• Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response

  2023cites this paper
• Letter to the Editor from Penning and Deltefsen "Hydroxyeicosatetraenoic Acid Controls Androgen Reduction in Diverse Types of Human Epithelial Cells".

  2023cites this paper
• Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer

  2023cites this paper
• Polyphenols as Antioxidant/Pro-Oxidant Compounds and Donors of Reducing Species: Relationship with Human Antioxidant Metabolism

  2023cites this paper
• Advances in developing noncovalent small molecules targeting Keap1.

  2023cites this paper
• Nrf2 Modulation in Breast Cancer

  2022cites this paper
• The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection

  2022cites this paper
• Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2.

  2022cites this paper
• Role of Nrf2 in Aging, Alzheimer's and Other Neurodegenerative Diseases.

  2022cites this paper
• Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1.

  2022cites this paper
• 5-hydroxyeicosatetraenoic acid controls androgen reduction in diverse types of human epithelial cells.

  2022cites this paper
• NADPH Oxidase 4 (NOX4) in Cancer: Linking Redox Signals to Oncogenic Metabolic Adaptation

  2022cites this paper
• Oxidation state-specific fluorescent copper sensors reveal oncogene-driven redox changes that regulate labile copper(II) pools

  2022cites this paper
• KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

  2022cites this paper
• The Intestinal Redox System and Its Significance in Chemotherapy-Induced Intestinal Mucositis

  2022cites this paper
• Role of the Glyoxalase System in Breast Cancer and Gynecological Cancer-Implications for Therapeutic Intervention: a Review

  2022cites this paper
• Availability of aldo-keto reductase 1C3 and ATP-binding cassette B1 as therapeutic targets for alleviating paclitaxel resistance in breast cancer MCF7 cells.

  2022cites this paper
• Aldo-Keto Reductases and Cancer Drug Resistance and Epigenetic Regulation of the Nuclear Factor-Erythroid 2 p45-Related Factor 2-Kelch-Like ECH-Associated Protein 1 Pathway Mediated by Aldo-Keto of Nuclear Factor-Erythroid 2 p45-Related Factor 2 and AKR Inhibitors to Surmount

  2021cites this paper
• Aldo-Keto Reductases and Cancer Drug Resistance and Epigenetic Regulation of the Nuclear Factor-Erythroid 2 p45-Related Factor 2-Kelch-Like ECH-Associated Protein 1 Pathway Mediated by Aldo-Keto of Nuclear Factor-Erythroid 2 p45-Related Factor 2 and AKR Inhibitors to Surmount

  2021cites this paper
• Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3

  2021cites this paper
• The Antioxidant Transcription Factor Nrf2 in Cardiac Ischemia–Reperfusion Injury

  2021cites this paper
• Development of cisplatin resistance in breast cancer MCF7 cells by up-regulating aldo-keto reductase 1C3 expression, glutathione synthesis, and proteasomal proteolysis.

  2021cites this paper
• Solving the Problem of Assessing Synergy and Antagonism for Non-Traditional Dosing Curve Compounds Using the DE/ZI Method: Application to Nrf2 Activators

  2021cites this paper
• Aldo-Keto Reductases and Cancer Drug Resistance

  2021cites this paper
• The Role of AKR1B10 in Physiology and Pathophysiology

  2021cites this paper
• The nexus between redox state and intermediary metabolism

  2021cites this paper
• The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism

  2021cites this paper
• FAM129B‐dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells

  2021cites this paper
• Positive and Negative Regulation of Ferroptosis and Its Role in Maintaining Metabolic and Redox Homeostasis

  2021cites this paper
• Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells

  2021cites this paper
• Metabolic reprogramming in the arsenic carcinogenesis.

  2021cites this paper
• Genetic ablation of Nrf2 exacerbates neurotoxic effects of acrylamide in mice.

  2021cites this paper
• Protective Effect of Aldo–keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4′-Fluoro-α-pyrrolidinononanophenone

  2021cites this paper
• Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells.

  2020cites this paper
• NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer

  2020cites this paper
• Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models

  2020cites this paper
• Computational repositioning of dimethyl fumarate for treating alcoholic liver disease

  2020cites this paper
• Oxidative Stress in Cancer.

  2020cites this paper
• Nrf2 is activated by disruption of mitochondrial thiol homeostasis but not by enhanced mitochondrial superoxide production

  2020cites this paper
• Acute effects of dietary plant nutrients on transcriptome profiles: evidence from human studies

  2020cites this paper
• Early Life Oxidative Stress and Long-Lasting Cardiovascular Effects on Offspring Conceived by Assisted Reproductive Technologies: A Review

  2020cites this paper
• Nrf2/HO-1 Mediated Antioxidant Activities, Cytotoxicity Analysis and LCESI/ MS Profiling of Eulophia nuda L.

  2020cites this paper
• NRF2 as a regulator of cell metabolism and inflammation in cancer.

  2020cites this paper
• Therapeutic effects of CO-releaser/Nrf2 activator hybrids (HYCOs) in the treatment of skin wound, psoriasis and multiple sclerosis

  2020cites this paper
• The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway

  2020cites this paper
• The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives

  2020cites this paper
• Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder

  2020cites this paper
• Identification of heme oxygenase-1 from golden pompano (Trachinotus ovatus) and response of Nrf2/HO-1 signaling pathway to copper-induced oxidative stress.

  2020cites this paper
• Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis.

  2020cites this paper
• Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration.

  2020cites this paper
• Potential Applications of NRF2 Modulators in Cancer Therapy

  2020cites this paper
• Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity

  2020cites this paper
• ACROLEIN AND UNSATURATED ALDEHYDES

  2020cites this paper
• Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review

  2020cites this paper
• The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure

  2019cites this paper
• Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1

  2019cites this paper
• Establishment of Nrf2-deficient HaCaT and immortalized primary human foreskin keratinocytes and characterization of their responses to ROS-induced cytotoxicity.

  2019cites this paper
• Telluric acid ameliorates hepatic ischemia reperfusion-induced injury in rats: Involvement of TLR4, Nrf2, and PI3K/Akt signaling pathways.

  2019cites this paper
• University of Dundee Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH 1

  2019cites this paper
• FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding

  2019cites this paper
• Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.

  2019cites this paper
• University of Dundee Measuring the Interaction of Transcription Factor Nrf 2 with Its Negative Regulator Keap 1 in Single Live Cells by an Improved FRET / FLIM Analysis

  2019cites this paper
• Genome-Wide CRISPR Screen Reveals Autophagy Disruption as the Convergence Mechanism That Regulates the NRF2 Transcription Factor

  2019influential citation
• Measuring the Interaction of Transcription Factor Nrf2 with Its Negative Regulator Keap1 in Single Live Cells by an Improved FRET/FLIM Analysis.

  2019cites this paper
• Does Bach1 & c-Myc dependent redox dysregulation of Nrf2 & adaptive homeostasis decrease cancer risk in ageing?

  2019cites this paper
• Retinoid X receptor α (RXRα)‐mediated erythroid‐2‐related factor‐2 (NRF2) inactivation contributes to N,N‐dimethylformamide (DMF)‐induced oxidative stress in HL‐7702 and HuH6 cells

  2019cites this paper
• Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease

  2019cites this paper
• The discovery and characterization of K‐563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp

  2019cites this paper
• Ferroptosis in Nervous System Diseases

  2019cites this paper
• Induction of the Antioxidant Response by the Transcription Factor NRF2 Increases Bioactivation of the Mutagenic Air Pollutant 3-Nitrobenzanthrone in Human Lung Cells.

  2019cites this paper
• TLR4 activation alters labile heme levels to regulate BACH1 and heme oxygenase-1 expression in macrophages.

  2019cites this paper
• Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway.

  2019cites this paper
• Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

  2019cites this paper